ClosedUnited Kingdom
Provision of Breyanzi CAR POS T-Cells
- Published
- Published 29 June 2026
Overview
The Clatterbridge Cancer Centre NHS Foundation Trust has procured Breyanzi CAR POS T-Cells, specialist immunotherapy products to be supplied directly. Bristol-Myers Squibb Pharmaceuticals Limited was awarded the contract on 28 June 2026 for £140,250, with the procurement now complete and in delivery.
Key details
- Country
- United Kingdom
- Status
- Closed
- Procedure
- Direct
- Published
- 29 June 2026
Award outcome
- Awarded value
- £140,250
- Award date
- 28 June 2026
- Contract period
- 30 June 2026 → 2 July 2026
- BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
29 June 2026
View notice ↗Contract
29 June 2026
View notice ↗
Contracting authority
The Clatterbridge Cancer Centre NHS Foundation Trust
BuyerBebington, Wirral, United Kingdom
GB-PPON: PPHY-1169-GBXY
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.